Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab
Shuhei Takahashi, S. Narita, N. Fujiyama, S. Hatakeyama, Takashi Kobayashi, Renpei Kato, S. Naito, T. Sakatani, S. Kashima, A. Koizumi, Ryohei Yamamoto, Nara Taketoshi, Souhei Kanda, K. Numakura, M. Saito*, W. Obara, N. Tsuchiya, C. Ohyama, O. Ogawa, T. Habuchi
Cancer Science